• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国西南地区汉族人群早期慢性肾脏病患者肠道菌群改变的病例对照研究。

Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China.

机构信息

Department of Nephrology, the Traditional Chinese Medicine Hospital Affiliated with Southwest Medical University, Luzhou, China.

出版信息

J Int Med Res. 2020 Jun;48(6):300060520926033. doi: 10.1177/0300060520926033.

DOI:10.1177/0300060520926033
PMID:32495708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7273791/
Abstract

OBJECTIVE

In this case-control study, we retrospectively analyzed the intestinal flora compositions of patients with early-stage chronic kidney disease (CKD).

METHODS

Forty-seven patients with early CKD who were treated at the Traditional Chinese Medicine Hospital between March and October 2018 were enrolled, and 150 healthy volunteers were enrolled in the healthy control group. Fresh stool samples were collected. The V3-V4 region of the bacterial 16S rRNA was amplified via PCR. Biterminal sequencing was performed using the Illumina MiSeq platform. The flora compositions were compared between the two groups.

RESULTS

The Chao1 and Shannon indices showed significantly lower intestinal flora diversity and abundances in the CKD group than in the healthy controls. Beta diversity analysis revealed notable differences in the intestinal flora compositions between the groups. At the phylum level, Actinobacteria and Proteobacteria abundances were significantly higher in the CKD group. Thirty-one species differed significantly between both groups, among which, differences in and displayed the highest diagnostic values for distinguishing CKD patients from healthy controls.

CONCLUSIONS

Intestinal flora compositions are altered in early-stage CKD patients among the Han population in southwestern China.

摘要

目的

在这项病例对照研究中,我们回顾性分析了早期慢性肾脏病(CKD)患者的肠道菌群组成。

方法

2018 年 3 月至 10 月期间,我们招募了在中医院接受治疗的 47 例早期 CKD 患者作为病例组,并招募了 150 名健康志愿者作为健康对照组。采集新鲜粪便样本。采用 PCR 扩增细菌 16S rRNA 的 V3-V4 区。使用 Illumina MiSeq 平台进行双端测序。比较两组之间的菌群组成。

结果

CKD 组的 Chao1 和 Shannon 指数均显示肠道菌群多样性和丰度显著低于健康对照组。β多样性分析显示两组之间的肠道菌群组成存在显著差异。在门水平上,CKD 组中放线菌和变形菌的丰度显著较高。两组之间有 31 个种存在显著差异,其中 和 的差异显示出区分 CKD 患者和健康对照者的最高诊断价值。

结论

在中国西南部汉族人群中,早期 CKD 患者的肠道菌群组成发生了改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/c076954ea4ad/10.1177_0300060520926033-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/e4bb82870271/10.1177_0300060520926033-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/eeca02897acd/10.1177_0300060520926033-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/069a553a3654/10.1177_0300060520926033-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/a36e78c62c83/10.1177_0300060520926033-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/c076954ea4ad/10.1177_0300060520926033-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/e4bb82870271/10.1177_0300060520926033-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/eeca02897acd/10.1177_0300060520926033-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/069a553a3654/10.1177_0300060520926033-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/a36e78c62c83/10.1177_0300060520926033-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fb/7273791/c076954ea4ad/10.1177_0300060520926033-fig5.jpg

相似文献

1
Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China.中国西南地区汉族人群早期慢性肾脏病患者肠道菌群改变的病例对照研究。
J Int Med Res. 2020 Jun;48(6):300060520926033. doi: 10.1177/0300060520926033.
2
Characterizing the gut microbiota in patients with chronic kidney disease.分析慢性肾脏病患者的肠道微生物群。
Postgrad Med. 2020 Aug;132(6):495-505. doi: 10.1080/00325481.2020.1744335. Epub 2020 Apr 2.
3
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.肠道微生物群的改变及其与慢性肾脏病中炎症因子的相关性。
Front Cell Infect Microbiol. 2019 Jun 12;9:206. doi: 10.3389/fcimb.2019.00206. eCollection 2019.
4
Blood Microbiome Profile in CKD : A Pilot Study.慢性肾脏病中的血液微生物组特征:一项初步研究。
Clin J Am Soc Nephrol. 2019 May 7;14(5):692-701. doi: 10.2215/CJN.12161018. Epub 2019 Apr 8.
5
[Characteristics of intestinal flora in patients with primary Sjögren syndrome].[原发性干燥综合征患者肠道菌群的特征]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Jul 30;40(7):949-957. doi: 10.12122/j.issn.1673-4254.2020.07.06.
6
High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.高通量测序分析终末期肾病和慢性肾脏病患者肠道菌群变化。
BMC Nephrol. 2020 Jan 13;21(1):12. doi: 10.1186/s12882-019-1668-4.
7
The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns.慢性肾脏病中与疾病模式相关的肠道微生物菌群组成和功能失衡。
J Transl Med. 2024 Aug 16;22(1):773. doi: 10.1186/s12967-024-05578-w.
8
[Correlation study between changes in intestinal microflora structure and immune indexes in newly treated patients with pulmonary tuberculosis].初治肺结核患者肠道菌群结构变化与免疫指标的相关性研究
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Dec 6;55(12):1486-1490. doi: 10.3760/cma.j.cn112150-20210728-00721.
9
Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.3-4 期慢性肾脏病患者肠道微生物群特征:一项回顾性队列研究。
Int Urol Nephrol. 2024 May;56(5):1751-1762. doi: 10.1007/s11255-023-03893-7. Epub 2023 Dec 12.
10
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.克罗恩病患者粪便微生物群落中产生丁酸盐的细菌种类丰度降低
Digestion. 2016;93(1):59-65. doi: 10.1159/000441768. Epub 2016 Jan 14.

引用本文的文献

1
Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut-Kidney Axis.探讨通过肠-肾轴在慢性肾脏病中益生菌的预防和治疗机制。
J Agric Food Chem. 2024 Apr 17;72(15):8347-8364. doi: 10.1021/acs.jafc.4c00263. Epub 2024 Apr 4.
2
The Combinational Effect of Inulin and Resveratrol on the Oxidative Stress and Inflammation Level in a Rat Model of Diabetic Nephropathy.菊粉与白藜芦醇对糖尿病肾病大鼠模型氧化应激和炎症水平的联合作用
Curr Dev Nutr. 2023 Dec 10;8(1):102059. doi: 10.1016/j.cdnut.2023.102059. eCollection 2024 Jan.
3
Gut-Kidney-Heart: A Novel Trilogy.

本文引用的文献

1
Chronic Kidney Disease Diagnosis and Management: A Review.慢性肾脏病的诊断与管理:综述。
JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745.
2
, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide.,一种与克罗恩病相关的人类肠道微生物组的成员,产生一种炎症性多糖。
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12672-12677. doi: 10.1073/pnas.1904099116. Epub 2019 Jun 10.
3
Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review.
肠-肾-心:一部全新的三部曲
Biomedicines. 2023 Nov 15;11(11):3063. doi: 10.3390/biomedicines11113063.
4
The Gut-Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics.人体内的肠-器官轴:肠道菌群失调与益生元的作用
Life (Basel). 2023 Oct 8;13(10):2023. doi: 10.3390/life13102023.
5
Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia.早期慢性肾脏病合并高尿酸血症患者肠道微生物群和代谢组的改变
Heliyon. 2023 Sep 20;9(9):e20328. doi: 10.1016/j.heliyon.2023.e20328. eCollection 2023 Sep.
6
Gut Microbiota Interventions to Retain Residual Kidney Function.肠道微生物群干预以保留残余肾功能。
Toxins (Basel). 2023 Aug 11;15(8):499. doi: 10.3390/toxins15080499.
7
Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes-A Systematic Review.慢性肾脏病中的肠道微生物群:从组成到调节以实现更好的结局——一项系统综述
J Clin Med. 2023 Mar 1;12(5):1948. doi: 10.3390/jcm12051948.
8
Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).肠道微生物群与西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)中肾功能和损伤的关联。
Gut Microbes. 2023 Jan-Dec;15(1):2186685. doi: 10.1080/19490976.2023.2186685.
9
Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review.新型生物标志物助力急性肾损伤早期检测:综述
Diseases. 2022 Dec 30;11(1):8. doi: 10.3390/diseases11010008.
10
Panax notoginseng saponins alleviate damage to the intestinal barrier and regulate levels of intestinal microbes in a rat model of chronic kidney disease.三七总皂苷可减轻慢性肾脏病大鼠模型肠屏障损伤并调节肠道微生物水平。
Ren Fail. 2022 Dec;44(1):1948-1960. doi: 10.1080/0886022X.2022.2143378.
慢性肾脏病患者的胃肠道微生物群:系统评价。
Adv Nutr. 2019 Sep 1;10(5):888-901. doi: 10.1093/advances/nmz028.
4
[Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects].肾移植受者、慢性肾病患者及健康受试者的肠道微生物群
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1401-1408. doi: 10.12122/j.issn.1673-4254.2018.12.01.
5
Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.微生物组-代谢组揭示了肠道-肾脏轴对肾脏疾病的影响。
J Transl Med. 2019 Jan 3;17(1):5. doi: 10.1186/s12967-018-1756-4.
6
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?免疫介导的炎症性疾病的肠道微生物组比较研究——是否存在共同的菌群失调?
Microbiome. 2018 Dec 13;6(1):221. doi: 10.1186/s40168-018-0603-4.
7
Rules of engagement in the gut microbiome.肠道微生物群中的参与规则。
Nat Med. 2018 Nov;24(11):1642-1644. doi: 10.1038/s41591-018-0242-0.
8
Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model.罗伊氏乳杆菌与饮食的相互作用可调节小鼠模型的动脉粥样硬化形成。
Nat Microbiol. 2018 Dec;3(12):1461-1471. doi: 10.1038/s41564-018-0272-x. Epub 2018 Nov 5.
9
Altered gut microbiota and microbial biomarkers associated with chronic kidney disease.与慢性肾脏病相关的肠道微生物群改变和微生物生物标志物。
Microbiologyopen. 2019 Apr;8(4):e00678. doi: 10.1002/mbo3.678. Epub 2018 Aug 7.
10
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.肠道微生物衍生代谢物与非酒精性脂肪性肝病肝脂肪变性和纤维化的共享基因效应之间的关系。
Hepatology. 2018 Sep;68(3):918-932. doi: 10.1002/hep.29892. Epub 2018 May 20.